Fri Jan 03 06:17:50 UTC 2025: ## China Battles Rise in Human Metapneumovirus (HMPV) Infections
**BEIJING** – Five years after the COVID-19 pandemic, China is grappling with a surge in human metapneumovirus (HMPV) infections, prompting authorities to issue public health advisories. The respiratory virus, first identified in 2001, is causing concern, particularly among children under 14 in northern provinces.
While HMPV is a known respiratory pathogen, its recent increase has led the Chinese Center for Disease Control and Prevention (CDC) to recommend preventative measures such as mask-wearing in crowded areas, frequent handwashing, and social distancing. The CDC has also emphasized good hygiene, proper ventilation, and a healthy lifestyle.
The virus, spread through respiratory droplets, typically presents with cold-like symptoms such as cough, fever, and nasal congestion. However, severe cases can lead to bronchitis or pneumonia, particularly in young children, the elderly, and those with underlying health conditions. While there is no vaccine, treatment focuses on managing symptoms with over-the-counter medications. Authorities warn against the indiscriminate use of antiviral drugs.
The National Disease Control and Prevention Administration has implemented new protocols for laboratory reporting and case verification, aiming to improve preparedness compared to the early stages of the COVID-19 outbreak. While officials predict lower overall respiratory infection numbers this year than last, the rise in HMPV cases, along with other respiratory viruses like rhinovirus, is prompting close monitoring, particularly in light of the seasonal increase in such infections. The government is also piloting a system for monitoring pneumonia of unknown origin. Although severe HMPV cases are relatively rare, studies have indicated that it can be fatal in a small percentage of young children with acute lower respiratory infections.
First Piper 